Related Experiment Video
Updated: Nov 21, 2025
07:15
Robust Ligature-Induced Model of Murine Periodontitis for the Evaluation of Oral Neutrophils
Published on: January 21, 2020
11.9K
[Is there an association between obesity and periodontitis?]
Nederlands Tijdschrift Voor Tandheelkunde
|January 15, 2021
Summary
This review found a weak link between obesity and periodontitis. Shared factors like inflammation and lifestyle issues contribute to both conditions, suggesting a complex relationship beyond direct causation.
Area of Science:
- Oral Health
- Metabolic Diseases
- Public Health
Background:
- Periodontitis and obesity are complex, multifactorial diseases affecting global populations.
- Both conditions share common underlying physiological and socio-economic factors.
- Understanding their interplay is crucial for effective public health strategies.
Purpose of the Study:
- To review the scientific literature on the association between obesity and periodontitis.
- To identify shared risk factors and physiological mechanisms linking these two conditions.
- To elucidate the complex relationship between metabolic health and periodontal disease.
Main Methods:
- A comprehensive literature review was conducted.
- Searched databases for studies investigating obesity and periodontitis.
- Synthesized findings on physiological, lifestyle, and socio-economic factors.
Main Results:
- A weak association was observed between obesity and periodontitis.
- Increased inflammatory state is a common physiological mechanism in both conditions.
- Shared socio-economic factors, low health literacy, and unhealthy lifestyles are prevalent in individuals with either condition.
Conclusions:
- The association between obesity and periodontitis is weak but complex.
- Shared inflammatory pathways and lifestyle factors play a significant role.
- Addressing these common factors may offer a dual benefit for public health.
Related Concept Videos
01:24Obesity
930
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
930
01:15Teeth
1.4K
The formation of teeth, also known as odontogenesis, is a complex process that begins in utero, around the sixth week of embryonic development. There are three stages to this process: the bud stage, the cap stage, and the bell stage.
In the bud stage, the tooth germ (an aggregation of cells) starts to form in the developing jawbone. During the cap stage, the tooth germ differentiates into enamel organ, dental papilla, and dental sac, which will later develop into the tooth's enamel, dentin...
In the bud stage, the tooth germ (an aggregation of cells) starts to form in the developing jawbone. During the cap stage, the tooth germ differentiates into enamel organ, dental papilla, and dental sac, which will later develop into the tooth's enamel, dentin...
1.4K
01:21Drug Dosing: Obese Patients
85
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
85
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
78
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
78
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
111
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
111
01:26Stress Prevention and Stress Management Techniques IV
120
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
120